StressMarq is the market leader in the development and commercialization of a range of unique fibrillar, oligomeric, and monomeric protein preparations 
for use in neurodegenerative disease research, including proteins such as alpha synuclein, tau, amyloid beta, SOD1 and TTR.
StressMarq’s strategic efforts are focused on expanding the breadth and depth of this product offering to assist researchers
studying Alzheimer’s, Parkinson’s, and other neurodegenerative diseases.
In addition to their focus on fibrillar proteins for neurodegenerative disease research, their diverse portfolio of antibodies, kits, small molecules,
and other proteins are utilized across a range of life sciences including neuroscience, cancer research and cell signaling.
 
 
 
 

DBA-ITALIA Srl
Via Umbria 10
20054 Segrate (Milano)
Tel. +39 02-26922300

If you no longer wish to receive these announcements click here